Amplia Therapeutics Financial Overview
Amplia Therapeutics's market cap is currently AU$64.13M. The company's EPS TTM is AU$-0.01; its P/E ratio is ―; Amplia Therapeutics is scheduled to report earnings on November 27, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
